Finance News World

Prostate Cancer Market Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

 Breaking News
  • No posts were found

Prostate Cancer Market Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

September 16
13:26 2021
Prostate Cancer Market Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
DelveInsight Business Research LLP
DelveInsight’s, “Prostate Cancer – Pipeline Insight, 2021,” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Prostate Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

DelveInsight’s “Prostate Cancer Pipeline Insight” report provides comprehensive insights about key companies and pipeline drugs in the Prostate Cancer Market pipeline landscapes. 

The report comprises Prostate Cancer pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Prostate Cancer Market therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Prostate Cancer Market pipeline products.     

Prostate Cancer Overview

Prostate cancer is a type of malignancy that occurs in the prostate gland, which is a part of the male reproductive system. Prostate cancer is the 3rdmost prevalent type of cancer in the US and the fourth most common worldwide. In the majority of the cases, the symptoms of prostate cancer are not apparent in the early stages of the disease. Due to the proximity of the prostate gland to the bladder and urethra, prostate cancer may be accompanied by a variety of urinary symptoms, especially in the early stages. Depending on its size and location, a tumor may press on and constrict the urethra, inhibiting the flow of urine. Furthermore, Prostate cancer may metastasize and form tumors in nearby organs or bones. If cancer spreads to the spine, it may press on the spinal nerves. Symptoms of Prostate Cancer often differ from patient to patient. 

Some of the key takeaways from the Prostate Cancer Pipeline Report:

  • Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as AstraZeneca/Merck Sharp & Dohme, Bristol-Myers Squibb, Novartis, Myovant Sciences, Janssen Research & Development, Hinova Pharmaceuticals USA, Hoffmann-La Roche, Pfizer/Astellas Pharma, Clovis Oncology, Advantagene or Candel Therapeutics, Merck Sharp & Dohme, etc., are developing therapies for the treatment of Prostate Cancer Market.

  • Emerging therapies such as Lynparza, Opdiv, Lutathera, Relugolix, Niraparib, HC-1119, Ipatasertib, Talazoparib, Rucaparib, ProstAtak, Keytruda, are expected to have a significant impact on the  Prostate Cancer Market market in the coming years.

Get an overview of pipeline landscape @ Prostate Cancer Clinical Trials Analysis 

Prostate Cancer Pipeline Therapies along with Key Players:

  1. Lynparza: AstraZeneca/Merck Sharp & Dohme 

  2. Opdivo: Bristol-Myers Squibb  

  3. Lutathera: Novartis  

  4. Relugolix: Myovant Sciences

  5. Niraparib: Janssen Research & Development 

  6. HC-1119: Hinova Pharmaceuticals USA

  7. Ipatasertib: Hoffmann-La Roche

  8. Talazoparib: Pfizer/Astellas Pharma 

  9. Rucaparib :Clovis Oncology 

  10. ProstAtak : Advantagene or Candel Therapeutics 

  11. Keytruda :Merck Sharp & Dohme, and others

Scope of Prostate Cancer Pipeline Drug Insight    

  • Coverage: Global 

  • Major Players: AstraZeneca/Merck Sharp & Dohme, Bristol-Myers Squibb, Novartis, Myovant Sciences, Janssen Research & Development, Hinova Pharmaceuticals USA, Hoffmann-La Roche, Pfizer/Astellas Pharma, Clovis Oncology, Advantagene or Candel Therapeutics, Merck Sharp & Dohme, and others.

  • Pipeline Therapies: Lynparza, Opdiv, Lutathera, Relugolix, Niraparib, HC-1119, Ipatasertib, Talazoparib, Rucaparib, ProstAtak, Keytruda, and others.

Table of Contents

1

Prostate Cancer Market Report Introduction

2

Prostate Cancer Market Executive Summary

3

Prostate Cancer Market Overview

4

Prostate Cancer Market- Analytical Perspective In-depth Commercial Assessment

5

Prostate Cancer Market Pipeline Therapeutics

6

Prostate Cancer Market Late Stage Products (Phase II/III)

7

Prostate Cancer Market Mid Stage Products (Phase II)

8

Prostate Cancer Market Early Stage Products (Phase I)

9

Prostate Cancer Market Preclinical Stage Products

10

Prostate Cancer Market Therapeutics Assessment

11

Prostate Cancer Market Inactive Products

12

Company-University Collaborations (Licensing/Partnering) Analysis

13

Prostate Cancer Market Key Companies

14

Prostate Cancer Market Key Products

15

Prostate Cancer Market Unmet Needs

16 

Prostate Cancer Market Market Drivers and Barriers

17

Prostate Cancer Market Future Perspectives and Conclusion

18

Prostate Cancer Market Analyst Views

19

Appendix

20

About DelveInsight

Get a customized pipeline report @ Prostate Cancer Drugs Pipeline Report  

Related Reports:

Prostate Cancer Market

DelveInsight’s ‘Prostate Cancer Market-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), 

Prostate Cancer Epidemiology

DelveInsight’s ‘Prostate Cancer Market Epidemiology Forecast to 2030′ report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/